Feb 12, 2026
During the quarter four new patents were granted, adding in total of seven new patent grants during 2025. This marks Neola Medical’s strongest year to date in terms of IP protection across all key target markets – Europe, the U.S. and China. In addition,...Nov 4, 2025
During the quarter Neola Medical strengthened the leadership team with appointment of a Clinical Director. In addition, the company’s IP portfolio was reinforced in Europe with a newly granted patent extending protection for lung monitoring beyond preterm born...Aug 25, 2025
Neola Medical advanced its U.S. regulatory pathway in the second quarter of 2025, signing an agreement with Children’s Regional Hospital at Cooper and securing IRB approval to enable the initiation of the pivotal clinical study on preterm born babies in the U.S....May 21, 2025
The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximately SEK 20 million, attracting new institutional investors including...Feb 12, 2025
Neola Medical achieved key milestones in 2024, instrumental to its planned FDA application: securing the CB certificate and successfully completing the Human Factors Validation study. These accomplishments mark the transition from the technical verification phase to...This website uses cookies to enhance your experience. Some are essential for site functionality, while others help us analyze and improve your usage experience. Please review your options and make your choice.
If you are under 16 years old, please ensure that you have received consent from your parent or guardian for any non-essential cookies.
Your privacy is important to us. You can adjust your cookie settings at any time. For more information about how we use data, please read our privacy policy. You may change your preferences at any time by clicking on the settings button below.
Note that if you choose to disable some types of cookies, it may impact your experience of the site and the services we are able to offer.
Some required resources have been blocked, which can affect third-party services and may cause the site to not function properly.
